Home
Made Scientific

七月 2026的Made Scientific市场份额分析

Discover Made Scientific, a pioneering force in cell therapy innovation. Learn how we're shaping the future with cutting-edge solutions to accelerate research and commercialization.

行业: 不适用

域madescientific.com

成立年份2019

员工51 - 200

年营收--

Made Scientific

Made Scientific（包含公司地区分支机构）

madescientific.com

查看更多网站流量和参与度信息

Made Scientific热门域名的总访问量

了解Made Scientific市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

madescientific.com3.2K

使用销售情报查看更多信息

Made Scientific热门域名的平均访问时长

分析Made Scientific参与度指标。

过去 3 个月的平均访问时长

子公司明细

madescientific.com00:00:36

使用销售情报查看更多信息

Made Scientific热门域名的平均页面浏览量

了解Made Scientific如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

madescientific.com1.96

使用销售情报查看更多信息

Made Scientific 排名靠前的竞争对手（按域名）

似乎没有足够的数据。

无数据可显示

Made Scientific 采用的主要技术

这些是排名前 Made Scientific 的顶级域名所使用的网站技术（按行业分列）

付款和货币 (3)

Visa

付费广告 (2)

TikTok Pixel

营销 (2)

Google Marketing Platform

移动设备 (2)

Meta Viewport

更多技术

9

查看全部

Made Scientific 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Pluristyx, Inc. integrated with Made Scientific, Inc. on Jun 4th '26.By aligning Pluristyx's iPSC reprogramming, engineering, and differentiation technology platforms and expertise with Made Scientific's GMP banking and downstream manufacturing capabilities under a single coordinated workflow, the companies give developers one point of accountability, removing the handoff risk and timeline drag that typically accompany bespoke iPSC programs.

新闻Made Scientific, Inc. signed new client Columbia Business School on Jun 1st '26.Made Scientific selected as manufacturer for Columbia University's autologous and allogeneic NOVAKnee program - a first-in-class living biologic total knee replacement.

新闻Cytorastem partners with Made Scientific, Inc..Dr. Serena's appointment comes as Cytora, together with its U.S. partners Made Scientific, Inc. and ZEO ScientifiX, Inc., advances its investigational novel allogeneic hOMSC therapy CytoraStem(TM) toward availability to patients under Florida's Senate Bill 1768, a stem cell access law enabling physician-delivered investigational stem cell therapies under defined conditions.